Showing results (61-70 of 92) with videos related to
Sort By:
Pageof 10
Journal of Medicinal Chemistry|July 17, 2007
Derivatives of (-)-7-methyl-2-(5-(pyridinyl)pyridin-3-yl)-7-azabicyclo[2.2.1]heptane are potential ligands for positron emission tomography imaging of extrathalamic nicotinic acetylcholine receptorsYongjun Gao, Andrew G Horti, Hiroto Kuwabara, et al.Biological Psychiatry|June 29, 2010
Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatientsUdi E Ghitza, Kenzie L Preston, David H Epstein, et al.Journal of Labelled Compounds & Radiopharmaceuticals|April 24, 2023
RO6807936 as a novel positron emission tomography (PET) radiotracer for in vitro and in vivo visualization and quantification of beta-site amyloid precursor protein cleaving enzyme (BACE1) in the rodent and baboon brainMichael Honer, Alessandra Polara, Hiroto Kuwabara, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptorsAndrew G Horti, Hong Fan, Hiroto Kuwabara, et al.Journal of Medicinal Chemistry|July 9, 2008
Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging propertiesYongjun Gao, Hiroto Kuwabara, Charles E Spivak, et al.Bioorganic & Medicinal Chemistry|June 2, 2009
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomographyYongjun Gao, Hayden T Ravert, Hiroto Kuwabara, et al.Translational Psychiatry|September 14, 2021
Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squaresGwenn S Smith, Clifford I Workman, Hillary Protas, et al.Journal of Parkinson'S Disease|February 20, 2025
Cortical α4β2-nicotinic acetylcholine receptors and cognitive decline in Parkinson's diseaseKelly A Mills, Hiroto Kuwabara, Yong Du, et al.Journal of Neurochemistry|November 9, 2007
VMAT2 and dopamine neuron loss in a primate model of Parkinson's diseaseMing-Kai Chen, Hiroto Kuwabara, Yun Zhou, et al.The Journal of Pain|September 27, 2022
Preliminary Evidence for the Sequentially Mediated Effect of Racism-Related Stress on Pain Sensitivity Through Sleep Disturbance and Corticolimbic Opioid Receptor FunctionJanelle E Letzen, Carly Hunt, Hiroto Kuwabara, et al.Pageof 10